Search research articles
Contact Us
Filters
Showing results (1-10 of 94) with videos related to
Page
of 10
Sort By:
Journal of Thrombosis and Haemostasis : JTH
|
October 25, 2025
Direct oral anticoagulant (DOAC) levels, bleeding, and breakthrough thrombosis: fog of war
Joseph R Shaw
Journal of Thrombosis and Haemostasis : JTH
|
February 28, 2026
Anticoagulation Reversal and Iatrogenic Stroke - A Double-Edged Sword
Joseph R Shaw
Journal of Thrombosis and Haemostasis : JTH
|
May 22, 2026
A Light in the Dark - Reframing DOAC Pharmacokinetics and Pharmacodynamics for Near-Patient Decision-Making
Joseph R Shaw, Jack Ansell
Journal of Thrombosis and Haemostasis : JTH
|
April 30, 2025
Emergent cardiac surgery, andexanet alfa-induced heparin resistance, and prothrombotic effects: coagulation chaos?
Joseph R Shaw, Jerrold H Levy
Anesthesiology
|
June 10, 2025
Perioperative Use of Activated Prothrombin Complex Concentrates
Anil K Panigrahi, Joseph R Shaw
Research and Practice in Thrombosis and Haemostasis
|
July 27, 2018
Pharmacological reversal of the direct oral anticoagulants-A comprehensive review of the literature
Joseph R Shaw, Deborah M Siegal
Research and Practice in Thrombosis and Haemostasis
|
July 21, 2020
Prothrombin complex concentrates for DOAC-associated bleeding, global coagulation assays, and assessments of clinical hemostasis: How to gauge the impact?
Joseph R Shaw, Deborah M Siegal
European Heart Journal. Cardiovascular Pharmacotherapy
|
March 13, 2026
Targeted Anticoagulant Reversal, Unintended Consequences: Lessons From Andexanet Alfa
Jerrold H Levy, Joseph R Shaw
The Medical Clinics of North America
|
June 8, 2020
Periprocedural Management of Oral Anticoagulation
Joseph R Shaw, Eric Kaplovitch, James Douketis
Critical Care Clinics
|
June 1, 2020
Thrombolysis in Pulmonary Embolism: An Evidence-Based Approach to Treating Life-Threatening Pulmonary Emboli
Eric Kaplovitch, Joseph R Shaw, James Douketis
Page
of 10
Search research articles
Search
Showing results (1-10 of 94) with videos related to
Sort By:
Page
of 10
Journal of Thrombosis and Haemostasis : JTH
|
October 25, 2025
Direct oral anticoagulant (DOAC) levels, bleeding, and breakthrough thrombosis: fog of war
Joseph R Shaw
Journal of Thrombosis and Haemostasis : JTH
|
February 28, 2026
Anticoagulation Reversal and Iatrogenic Stroke - A Double-Edged Sword
Joseph R Shaw
Journal of Thrombosis and Haemostasis : JTH
|
May 22, 2026
A Light in the Dark - Reframing DOAC Pharmacokinetics and Pharmacodynamics for Near-Patient Decision-Making
Joseph R Shaw, Jack Ansell
Journal of Thrombosis and Haemostasis : JTH
|
April 30, 2025
Emergent cardiac surgery, andexanet alfa-induced heparin resistance, and prothrombotic effects: coagulation chaos?
Joseph R Shaw, Jerrold H Levy
Anesthesiology
|
June 10, 2025
Perioperative Use of Activated Prothrombin Complex Concentrates
Anil K Panigrahi, Joseph R Shaw
Research and Practice in Thrombosis and Haemostasis
|
July 27, 2018
Pharmacological reversal of the direct oral anticoagulants-A comprehensive review of the literature
Joseph R Shaw, Deborah M Siegal
Research and Practice in Thrombosis and Haemostasis
|
July 21, 2020
Prothrombin complex concentrates for DOAC-associated bleeding, global coagulation assays, and assessments of clinical hemostasis: How to gauge the impact?
Joseph R Shaw, Deborah M Siegal
European Heart Journal. Cardiovascular Pharmacotherapy
|
March 13, 2026
Targeted Anticoagulant Reversal, Unintended Consequences: Lessons From Andexanet Alfa
Jerrold H Levy, Joseph R Shaw
The Medical Clinics of North America
|
June 8, 2020
Periprocedural Management of Oral Anticoagulation
Joseph R Shaw, Eric Kaplovitch, James Douketis
Critical Care Clinics
|
June 1, 2020
Thrombolysis in Pulmonary Embolism: An Evidence-Based Approach to Treating Life-Threatening Pulmonary Emboli
Eric Kaplovitch, Joseph R Shaw, James Douketis
Page
of 10